U.S. International Trade Commission Ends Investigation into Apple’s Redesigned Products
Estimated reading time: 3–5 minutes
The U.S. International Trade Commission (ITC) has announced the conclusion of its investigation into Apple Inc.’s redesigned light-based physiological measurement devices. The investigation, known as No. 337-TA-1276, focused on whether Apple’s new devices infringed upon patents held by Masimo Corporation and Cercacor Laboratories, Inc.
The investigation began in August 2021. Masimo and Cercacor alleged that Apple’s devices violated section 337 of the Tariff Act of 1930 by infringing on their patents. The ITC found that some of Apple’s products did infringe certain patent claims.
In October 2023, the ITC issued a final decision. They found that some of Apple’s products violated specific claims of Masimo’s patents. The ITC issued a limited exclusion order (LEO) and a cease and desist order against Apple.
In September 2025, Masimo requested the ITC to modify the orders. They wanted clarification on whether Apple’s new product designs still violated their patents.
In November 2025, the ITC started a new proceeding to examine Apple’s redesigned devices. The goal was to see if these products infringed any patents.
On March 18, 2026, an Administrative Law Judge (ALJ) decided that Apple’s redesigned products did not violate any of the asserted patent claims. Masimo and Apple each requested a review of this decision.
On April 17, 2026, the ITC decided not to review the ALJ’s decision. This means the investigation is now closed. The ITC will not exclude Apple’s redesigned products from the market.
This decision was made under section 337 of the Tariff Act of 1930 and the ITC’s Rules of Practice and Procedure.
Legal Disclaimer
This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
